Proteins are an important class of biological macromolecules composed of amino acids present in living organisms. They play a variety of important roles, including participating in the metabolism, transportation, and transmission of nerve impulses in the body in organisms, and they are important molecules necessary to maintain life activities. Peptides are proteins of low molecular weight, usually consisting of less than 50 amino acid residues. Similar to proteins, peptides also play various important biological roles.
Ace Therapeutics offers hundreds of natural and recombinant proteins & peptides for stroke research, including but not limited to, cytokines, neuroprotective proteins, apoptotic factors, and inflammatory mediators.
Importantly, each of our products is verified by standard quality control procedures and tested for biological activity and low endotoxicity.
Please access our all-series proteins & peptides or contact our scientist for personalized assistance.
| Cat.# | Name | Size | Description | Price |
|---|---|---|---|---|
| ACPP-1211 | Beta crystallin S Blocking Peptide (AC1211) | 250 µg |
Beta crystallin S Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
| ACPP-1212 | PAX8 Blocking Peptide (AC1212) | 250 µg |
PAX8 Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
| ACPP-1213 | CACNB2 Blocking Peptide (AC1213) | 250 µg |
CACNB2 Blocking Peptide for Immmunodepletion, Competition Assay
|
inquiry |
| ACPP-1214 | Ki67 Blocking Peptide (AC1214) | 250 µg |
Ki67 Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
| ACPP-1215 | PINK1 Blocking Peptide (AC1215) | 250 µg |
PINK1 Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
| ACPP-1216 | PARD3 Blocking Peptide (AC1216) | 250 µg |
PARD3 Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
| ACPP-1217 | P2Y2 Blocking Peptide (AC1217) | 250 µg |
P2Y2 Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
| ACPP-1218 | Dopamine D2 Receptor Blocking Peptide (AC1218) | 250 µg |
Dopamine D2 Receptor Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
| ACPP-1219 | Prominin 1 Blocking Peptide (AC1219) | 250 µg |
Prominin 1 Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
| ACPP-1220 | ELOVL4 Blocking Peptide (AC1220) | 250 µg |
ELOVL4 Blocking Peptide for Immunocompetition, Immunodepletion
|
inquiry |
| ACPP-1221 | Bestrophin Blocking Peptide (AC1221) | 250 µg |
Bestrophin Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
| ACPP-1222 | ALDH1A1 Blocking Peptide (AC1222) | 250 µg |
ALDH1A1 Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
| ACPP-1223 | PAX8 Blocking Peptide (AC1223) | 250 µg |
PAX8 Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
| ACPP-1224 | LAMP1 Blocking Peptide (AC1224) | 250 µg |
LAMP1 Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
| ACPP-1225 | POMT1 Blocking Peptide (AC1225) | 250 µg |
POMT1 Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.